- Previous Close
0.0000 - Open
0.6000 - Bid 0.5000 x --
- Ask 0.5800 x --
- Day's Range
0.6000 - 0.6000 - 52 Week Range
0.0005 - 0.8000 - Volume
1,204 - Avg. Volume
249 - Market Cap (intraday)
44.615M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada.
www.zyus.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ZLSCF
View MorePerformance Overview: ZLSCF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZLSCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZLSCF
View MoreValuation Measures
Market Cap
40.79M
Enterprise Value
46.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
133.97
Price/Book (mrq)
4.26
Enterprise Value/Revenue
145.12
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-22.33%
Return on Equity (ttm)
-118.64%
Revenue (ttm)
452k
Net Income Avi to Common (ttm)
-36.55M
Diluted EPS (ttm)
-0.4100
Balance Sheet and Cash Flow
Total Cash (mrq)
346k
Total Debt/Equity (mrq)
53.34%
Levered Free Cash Flow (ttm)
-2.63M